Biologic Therapy Tied to Less Coronary Inflammation in Psoriasis
Anti-inflammatory biologic therapies are associated with reduced coronary inflammation in patients with psoriasis, a new study suggests.Investigators noted that after 1 year, the perivascular fat index (FAI) — a novel imaging biomarker that assesses coronary inflammation, measured by coronary computed tomography angiography (CCTA) — was significantly lower in patients treated with biologic therapies than in those in the control group, independent of the presence of coronary plaque. The findings are published online in J
Read the full story.
Create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies